Danube AG

Equities

DSFIR

CH1216478797

Consumer Goods Conglomerates

End-of-day quote Euronext Amsterdam 18:00:00 2024-06-13 EDT 5-day change 1st Jan Change
99.24 CHF +0.73% Intraday chart for Danube AG -0.54% +7.87%
LockThis Alphavalue article, the European leader in independent research, is only available to subscribers .
Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!
Already a customer? Log In
DSM-Firmenich Launches Voluntary Transfer Offer for Remaining DSM Shares MT
Dsm-firmenich to Sell Yeast Extract Business to France's Lesaffre MT
Lesaffre et Compagnie, SA agreed to acquire Yeast Extract Business of DSM-Firmenich. CI
Dsm-firmenich sees boost as weight-loss drugs spur healthier choices RE
Global markets live: GSK, Walt Disney, Blackstone, Boeing, Microsoft... Our Logo
Transcript : DSM-Firmenich AG - Analyst/Investor Day
Dsm-firmenich to De-prioritize Certain Business Activities Under New Strategy MT
DSM-Firmenich sees mid-term adjusted EBITDA margin of 22-23% RE
Dsm-firmenich to Build Centralized Financing Structure Under Cross Guarantee Deal MT
Elanco Says FDA Confirms Bovaer Meets Safety, Efficacy Requirements MT
Dsm-Firmenich Ag Approves Retirement of Pradeep Pant from the Board CI
Dsm-Firmenich Ag Approves the Dividend, Payable May 16, 2024 CI
Tranche Update on DSM-Firmenich AG's Equity Buyback Plan announced on April 8, 2024. CI
DSM-Firmenich AG's Equity Buyback announced on April 8, 2024, has closed with 1,500,000 shares, representing 0.57% for ?156.59 million. CI
Global markets live: Etsy, Qualcomm, Carvana, Rio Tinto, Apple... Our Logo
DSM-FIRMENICH : Vitamin trouble is going to fade Alphavalue
U.S. Futures Up, European Stocks Mixed in Wake of Fed Remarks DJ
Transcript : DSM-Firmenich AG, Q1 2024 Sales/ Trading Statement Call, May 02, 2024
U.S. Futures Down, European Stocks Mixed DJ
DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital. CI
DSM-Firmenich AG authorizes a Buyback Plan. CI
DSM-FIRMENICH : A stronger long-term outlook Alphavalue
Quiz sales fall, names new CEO; Byotrol eyes AIM exit AN
Quotes from Dutch companies on the worsening business climate RE
ASML's threat to leave uncovers deeper concerns in Netherlands Inc. RE
Chart Danube AG
More charts
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
99.24 EUR
Average target price
122.1 EUR
Spread / Average Target
+23.03%
Consensus
  1. Stock Market
  2. Equities
  3. DSFIR Stock
  4. News Danube AG
  5. DSM-Firmenich: Vitamin trouble is going to fade